RAFAEL
PÉREZ GARCÍA
Investigador hasta 2018
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (8)
2023
-
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration
Clinical Kidney Journal, Vol. 16, Núm. 11, pp. 2254-2261
2022
-
Advantages of the use of citrate over acetate as a stabilizer in hemodialysis fluid: A randomized ABC-treat study
Nefrologia, Vol. 42, Núm. 3, pp. 327-337
2021
-
Hemodialysis Centers Guide 2020
Nefrologia, Vol. 41, pp. 1-77
2019
-
Prospective randomized multicenter study to demonstrate the benefits of haemodialysis without acetate (with citrate): ABC-treat Study. Acute effect of citrate
Nefrologia, Vol. 39, Núm. 4, pp. 424-433
2017
-
The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
Journal of Computational Design and Engineering, Vol. 4, Núm. 3, pp. 665-675
2012
-
Epidemiological study of 7316 patients on haemodialysis treated in FME clinics in Spain, using data from the EuCliD® database: Results from years 2009-2010
Nefrologia, Vol. 32, Núm. 6, pp. 743-753
1998
-
Effects of L-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophospholipid acyltransferase in uremia
American Journal of Clinical Nutrition, Vol. 67, Núm. 3, pp. 386-390
1996
-
Reduced carnitine palmitoyl transferase activity and altered acyl-trafficking in red blood cells from hemodialysis patients
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1315, Núm. 1, pp. 37-39